High-Resolution Magnetic Resonance Angiography of the Mouse Brain: Application to Murine Focal Cerebral Ischemia Models

Journal of Magnetic Resonance

Volumn 140, Issue 2, 1999, Pages 442-450

  Beckmann, Nicolau ^a   Stirnimann, Roger ^a   Bochelen, Damien ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Angiography; Brain; Ischemia; Magnetic resonance angiography; Microscopy; Mouse; Stroke

Indexed keywords

CONTRAST MEDIUM;

ANIMAL; ARTICLE; BLOOD FLOW VELOCITY; BRAIN; BRAIN ANGIOGRAPHY; BRAIN ARTERY; BRAIN CIRCULATION; BRAIN ISCHEMIA; BRAIN VEIN; C57BL MOUSE; DISEASE MODEL; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; METHODOLOGY; MIDDLE CEREBRAL ARTERY; MOUSE; MOUSE STRAIN; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSIOLOGY; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; BLOOD FLOW VELOCITY; BRAIN; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; CEREBRAL ARTERIES; CEREBRAL VEINS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; ISCHEMIC ATTACK, TRANSIENT; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MIDDLE CEREBRAL ARTERY;

EID: 0033210843     PISSN: 10907807     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmre.1999.1864     Document Type: Article

References (38)

1. R. R. Edelman, MR angiography: Present and future, Am. J. Roentgenol. 161, 1-11 (1993).
2. S. L. Talagala, C. A. Jungreis, E. Kanal, S. P. Meyers, T. K. Foo, R. A. Rubin, and G. R. Applegate, Fast three-dimensional time-of-flight MR angiography of the intra-cranial vasculature, J. Magn. Reson. Imaging 5, 317-323 (1995).
3. S. C. Wang, M. G. Wikstrom, D. L. White, et al., Evaluation of Gd-DTPA labeled dextran as an intravascular contrast agent: Imaging characteristics in normal rat tissues, Radiology 175, 280-283 (1990).
4. G. Marchai, H. Bosmans, P. van Hecke, Y. B. Jiang, P. Aerts, and H. Bauer, Experimental Gd-DTPApolylysineenhanced MR angiography: Sequence optimization, J. Comput. Assist. Tomogr. 15, 711-715 (1991).
5. A. A. Bogdanov Jr., R. Weissleder, H. W. Frank, A. V. Bogdanov, N. Nossif, B. K. Schaffer, E. Tsai, M. I. Papisov, and T. J. Brady, A new macromolecule as a contrast agent for MR angiography: Preparation, properties and animal studies, Radiology 187, 701-706 (1993).
6. J. C. Bock, U. Pison, F. Kaufmann, and R. Felix, Gd-DTPA-polylysine-enhanced pulmonary time-of-flight MR angiography, J. Magn. Reson. Imaging 4, 473-476 (1994).
7. N. S. Cook, H.-G. Zerwes, C. Pally, M. Rudin, and R. P. Hof, Spirapril and cilazapril inhibit neointimal lesion development but cause no detectable inhibition of lumen narrowing after carotid artery balloon catheter injury in the rat, Blood Pressure 2, 322-331 (1993).
8. S. Wehr, M. Rudin, J. Joergensen, A. Hof, and R. P. Hof, Allo- and autotransplantation of carotid artery - A new model of chronic graft vessel disease, Transplantation 64, 20-27 (1997).
9. C. Yuan, M. P. Skinner, E. Kaneko, L. M. Mitsumori, C. E. Hayews, E. W. Raines, J. A. Nelson, and R. Ross, Magnetic resonance imaging to study lesions of atherosclerosis in the hyperlipidemic rabbit aorta, Magn. Reson. Imaging 14, 93-102 (1996).
10. A. J. Martin and R. M. Henkelman, Intravascular MR imaging in a porcine animal model, Magn. Reson. Med. 32, 224-229 (1994).
11. L. Arnder, X. Zhou, G. P. Cofer, L. W. Hedlund, and G. A. Johnson, Magnetic resonance microscopy of the rat carotid artery at 300 MHz, Invest. Radiol. 29, 822-826 (1994).
12. A. F. Mellin, G. P. Cofer, B. R. Smith, S. A. Suddarth, L. W. Hedlund, and G. A. Johnson, Three dimensional magnetic resonance microangiography of rat neurovasculature, Magn. Reson. Med. 32, 199-205 (1994).
13. T. Reese, D. Bochelen, A. Sauter, N. Beckmann, and M. Rudin, Magnetic resonance angiography of the rat cerebrovascular system without the use of contrast agents, NMR Biomed. 12, 189-196 (1999).
14. J. Koizumi, Y. Yoshida, T. Nakazawa, and G. Oneda, Experimental studies of ischemic brain edema. 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area, Jpn. J. Stroke 8, 1-8 (1986).
15. H. Kamii, H. Kinouchi, F. R. Sharp, C. J. Epstein, S. M. Sagar, and P. H. Chan, Expression of c-fos mRNA after a mild focal cerebral ischemia in SOD-1 transgenic mice, Brain Res. 662, 240-244 (1994).
16. H. Hara, P. L. Huang, N. Panahian, M. C. Fishman, and M. A. Moskowitz, Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion, J. Cereb. Flow Metab. 16, 605-611 (1996).
17. B. Pike, B. S. Hu, G. H. Glover, and D. R. Enzmann, Magnetization transfer time-of-flight magnetic resonance angiography, Magn. Reson. Med. 25, 372-379 (1992).
18. R. R. Edelman, S. S. Ahn, D. Chien, W. Li, A. Goldmann, M. Mantello, J. Kramer, and J. Kleefield, Improved time-of-flight angiography of the brain with magnetization transfer contrast, Radiology 184, 395-399 (1992).
19. W. Lin, J. A. Tkach, E. M. Haacke, and T. J. Marsaryk, Intracranial MR angiography: Application of magnetization transfer contrast and fat saturation to short gradient echo, velocity-compensated sequences, Radiology 186, 753-761 (1993).
20. R. Weissleder, G. Elizondo, J. Wittenberg, C. Rabito, H. Bengele, and L. Josephson, Ultrasmall superparamagnetic iron oxide: Characterization of a new class of contrast agents for MR imaging, Radiology 175, 489-493 (1990).
21. P. J. Mergo, T. Helmberger, A. I. Nicolas, and P. R. Ros, Ring enhancement in ultrasmall superparamagnetic iron oxide MR imaging: A potential new sign for characterization of liver lesions, Am. J. Roentgenol. 166, 379-384 (1996).
22. M. G. Harisinghani, S. Saini, R. Weissleder, et al., Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227, Radiology 202, 687-691 (1997).
23. Y. Anzai, M. R. Prince, T. L. Chevenert, et al., MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent, J. Magn. Reson. Imaging 7, 209-214 (1997).
24. W. Mayo-Smith, S. Saini, G. Slater, J. Kaufman, P. Sharma, and P. Hahn, MR contrast for vascular enhancement: Value of superpara-magnetic iron oxide, Am. J. Roentgenol. 166, 73-77 (1996).
25. A. Stillman, N. Wilke, D. Li, M. Haacke, and S. McLachlan, Ultrasmall superparamagnetic iron oxide to enhance MRA of the renal and coronary arteries: Studies in human patients, J. Comput. Assist. Tomogr. 20, 51-55 (1996).
26. E. S. Connolly Jr., C. J. Winfree, D. M. Stern, R. A. Solomon, and D. J. Pinsky, Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia, Neurosurgery38, 523-531 (1996).
27. K. Kitagawa, M. Matsumoto, G. Yang, T. Mabuchi, Y. Yagita, M. Hori, and T. Yanagihara, Cerebral ischemia after bilateral carotid artery occlusion and intraluminal suture occlusion in mice: Evaluation of the patency of the posterior communicating artery, J. Cereb. Flow Metab. 18, 570-579 (1998).
28. R. Hata, G. Mies, C. Wiessner, K. Fritze, D. Hesselbarth, G. Brinker, and K.-A. Hossmann, A reproducible model of middle cerebral artery occlusion in mice: Hemodynamic, biochemical, and magnetic resonance imaging, J. Cereb. Flow Metab. 18, 367-375 (1998).
29. H. Kinouchi, F. R. Sharp, J. Koistinaho, K. Hicks, H. Kamii, and P. H. Chan, Induction of heat shock hsp70 mRNA and HSP70 kDa protein in neurons in the "penumbra" following focal cerebral ischemia in the rat, Brain Res. 619, 334-338 (1993).
30. C. Wiessner, J. Gehrmann, D. Lindholm, R. Topper, G. W. Kreutzberg, and K.-A. Hossmann, Expression of transforming growth factor-beta 1 and interleukin-1 beta mRNA in rat brain following transient forebrain ischemia, Acta Neuropathol. 86, 439-446 (1993).
31. M. Buttini, K. Appel, A. Sauter, H. P. Gebicke, and H. W. Boddeke, Expression of tumor necrosis factor alpha after focal cerebral ischemia in the rat, Neuroscience 71, 1-16 (1996).
32. H. Kinouchi, F. R. Sharp, P. H. Chan, J. Koistinaho, S. M. Sagar, and T. Yoshimoto, Induction of c-fos, junB, c-jun, and hsp70 mRNA in cortex, thalamus, basal ganglia, and hippocampus following middle cerebral artery occlusion, J. Cereb. Flow Metab. 14, 808-817 (1994).
33. R. C. Crumrine, A. L. Thomas, and P. F. Morgan, Attenuation of p53 expression protects against focal ischemic damage in transgenic mice, J. Cereb. Flow Metab. 14, 887-891 (1994).
34. G. Yang, P. H. Chan, J. Chen, E. Carlson, S. F. Chen, P. Weinstein, C. J. Epstein, and H. Kamii, Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia, Stroke 25, 165-170 (1994).
35. P. H. Chan, H. Kamii, G. Yang, J. Gafni, C. J. Epstein, E. Carlson, and L. Reola, Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia, Neuroreport 5, 293-296 (1993).
36. A. J. Bruce, W. Boling, M. S. Kindy, J. Peschon, P. J. Kraemer, M. K. Carpenter, F. W. Holtsberg, and M. P. Mattson, Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors, Nature Med. 2, 788-794 (1996).
37. E. S. Connolly Jr., C. J. Winfree, T. A. Springer, Y. Naka, H. Liao, S. D. Yan, D. M. Stern, R. A. Solomon, R. J. Gutierrez-Ramos, and D. J. Pinsky, Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke, J. Clin. Invest. 97, 209-216 (1996).
38. F. C. Barone, D. J. Knudsen, A. H. Nelson, G. Z. Feuerstein, and R. N. Villette, Mouse strain differences in susceptibility to cerebral ischemia are related to cerebral vascular anatomy, J. Cereb. Flow Metab. 13, 683-692 (1993).